3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine is used as a starting reagent to synthesize imidazopyridine derivatives, compounds that inhibit receptor tyrosine kinases and can be used for cancer treatment.
Dangerous Goods Info:
WIlliams, B., et al. Imidazopyridine Derivatives As Inhibitors of Receptor Tyrosine Kinases and Their Preparation and Use In the Treatment of Cancer. US patent 20120208791. Aug 16, 2012.